Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by Skye Peptides.
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| BPC-157 | 17 | 98.52% | Sep 16, 2026 |
| Retatrutide | 13 | 99.41% | Sep 16, 2026 |
| Tirzepatide | 12 | 99.7% | May 11, 2026 |
| Semaglutide | 9 | 99.89% | Mar 20, 2025 |
| Ipamorelin | 8 | 99.04% | Sep 16, 2026 |
| Tesamorelin | 8 | 94.95% | Sep 21, 2026 |
| Mazdutide | 5 | 99.41% | Aug 16, 2025 |
| Melanotan II | 4 | 99.3% | Mar 20, 2025 |
| CJC-1295 No DAC | 4 | 98.87% | Mar 20, 2025 |
| Survodutide | 4 | 98.92% | May 21, 2025 |
| CJC-1295 DAC | 3 | 99.22% | May 20, 2025 |
| TB-500 Thymosin Beta-4 | 2 | 96.9% | Feb 20, 2026 |
| GHK-Cu | 2 | 99.8% | Aug 31, 2026 |
| TB-500 | 1 | 97.57% | Jul 24, 2025 |
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| Tesamorelin | TESA26-10-001 | 93.84% | Lab K | Sep 21, 2026 | verify |
| Ipamorelin | IPA25-10-003 | 99.43% | Lab K | Sep 16, 2026 | verify |
| Retatrutide | RET26-12-003 | 96.12% | Lab K | Sep 16, 2026 | verify |
| BPC-157 | BPC26-10-001 | 97.97% | Lab K | Sep 16, 2026 | verify |
| BPC-157 | BPC26-10-001 | 99.9% | Lab L | Sep 15, 2026 | verify |
| BPC-157 | BPC26-10-001 | 99.6% | Lab G | Aug 31, 2026 | verify |
| GHK-Cu | GHK25-50-002 | 99.7% | Lab G | Aug 31, 2026 | verify |
| Ipamorelin | IPA25-10-003 | 99.9% | Lab G | Aug 31, 2026 | verify |
| Ipamorelin | IPA25-10-003 | 94.53% | Lab K | Aug 27, 2026 | verify |
| BPC-157 | BPC26-10-001 | 99.34% | Lab K | Aug 27, 2026 | verify |
| BPC-157 | BPC26-10-001 | 98.02% | Lab K | Aug 27, 2026 | verify |
| Tesamorelin | TESA26-10-001 | 83.84% | Lab K | Aug 27, 2026 | verify |
| Tesamorelin | TESA26-10-001 | 85.23% | Lab K | Aug 27, 2026 | verify |
| Tirzepatide | TZ26-10-001 | 99.9% | Lab E | May 11, 2026 | verify |
| Retatrutide | RET26-12-001 | 99.2% | Lab E | Apr 23, 2026 | verify |
| GHK-Cu | 89030-95-5 | 99.9% | Lab E | Apr 11, 2026 | verify |
| Retatrutide | RET26-24-001 | 99.9% | Lab E | Apr 9, 2026 | verify |
| BPC-157 | BPC25-05-002 | 99.88% | Lab E | Feb 22, 2026 | verify |
| TB-500 Thymosin Beta-4 | TB25-10-003 | 94.04% | Lab E | Feb 20, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab E | Feb 18, 2026 | verify |
| Tesamorelin | n/a | 99.7% | Lab G | Feb 4, 2026 | verify |
| Ipamorelin | IPA-10-001 | 99.8% | Lab G | Feb 4, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab G | Jan 26, 2026 | verify |
| Tesamorelin | TESA25-10-004 | 98.65% | Lab E | Jan 9, 2026 | verify |
| TB-500 Thymosin Beta-4 | TB25-10-003 | 99.76% | Lab E | Jan 9, 2026 | verify |
Showing 25 most recent of 92. Search the full database on the CoA page.
Sell or represent Skye Peptides? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/skye-peptides/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/skye-peptides.svg" alt="Skye Peptides: lab tested, 92 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.